Lovelace Medical Center Recognized for Stroke Care

Congratulations to Lovelace Medical Center for receiving the American Heart Association/American Stroke Association’s Get With The Guidelines®–Stroke Gold Plus Quality Achievement Award.  The award recognizes Lovelace Medical Center’s commitment and success in implementing a higher standard of stroke care by ensuring that stroke patients receive treatment according to nationally accepted standards and recommendations.

Lovelace Medical Center achieved 85 percent or higher adherence to all Get With The Guidelines-Stroke Quality Achievement indicators for two or more consecutive 12-month intervals andachieved 75 percent or higher compliance with 6 of 10 Get With The Guidelines-Stroke Quality Measures.  These measures includeaggressive use of medications, such as antithrombotics, anticoagulation therapy, deep vein thrombosis prophylaxis, cholesterol reducing drugs and smoking cessation, all aimed at reducing death and disability and improving the lives of stroke patients.         

In addition to the Get WithThe Guidelines-Stroke award Lovelace Medical Center has also been recognized as a recipient of the association’s Target: Stroke Honor Roll, for improving stroke care.  Over the past quarter, at least 50 percent of the hospital’s eligible ischemic stroke patients have received tissue plasminogen activator, or tPA, within 60 minutes of arriving at the hospital (known as ‘door-to-needle’ time).   A thrombolytic, or clot-busting agent, tPA is the only drug approved by the U.S. Food and Drug Administration for the urgent treatment of ischemic stroke.  If given intravenously in the first three hours after the start of stroke symptoms, tPA has been shown to significantly reverse the effects of stroke and reduce permanent disability.

News and Events

Seminar: How Labor Works - the Wonders and Wisdom of the Mother-Baby Duo

Join Rebecca Leeman, CNM, from Women's Specialists of NM to find ou

Walgreens to Acquire Lovelace’s Retail Pharmacy Businesses

DEERFIELD, Ill., and ALBUQUERQUE, NM, March 9, 2015 – Walgreen Co.